New cell therapy trial offers hope for patients with tough blood cancers
NCT ID NCT07493174
Summary
This is an early-stage study to test the safety and find the right dose of a new experimental cell therapy called SYS6055. It is for adults with B-cell blood cancers, like certain leukemias and lymphomas, that have come back or not responded to standard treatments. The main goals are to see how well the treatment is tolerated and to check for any early signs that it might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY B-CELL MALIGNANCIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.